PortfoliosLab logo

Amryt Pharma plc (AMYT)

Equity · Currency in USD · Last updated Mar 22, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Amryt Pharma plc in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $12,951 for a total return of roughly 29.51%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2023FebruaryMarch
29.51%
26.28%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AMYT

Amryt Pharma plc

Return

Amryt Pharma plc had a return of 99.59% year-to-date (YTD) and 74.28% in the last 12 months. Over the past 10 years, Amryt Pharma plc had an annualized return of 10.06%, outperforming the S&P 500 benchmark which had an annualized return of 9.03%.


PeriodReturnBenchmark
1 month-0.41%-1.87%
Year-To-Date99.59%4.25%
6 months94.27%2.64%
1 year74.28%-10.31%
5 years (annualized)10.06%9.03%
10 years (annualized)10.06%9.03%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023100.41%-0.14%
2022-4.55%-1.30%4.25%2.53%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Amryt Pharma plc Sharpe ratio is 0.66. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00NovemberDecember2023FebruaryMarch
0.66
-0.44
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

Dividend History


Amryt Pharma plc doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2023FebruaryMarch
-1.35%
-16.55%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Amryt Pharma plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amryt Pharma plc is 57.29%, recorded on Mar 7, 2022. It took 214 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-57.29%Feb 17, 2021266Mar 7, 2022214Jan 11, 2023480
-16.67%Sep 10, 202010Sep 23, 202031Nov 5, 202041
-9.82%Nov 16, 202011Dec 1, 20204Dec 7, 202015
-8.44%Jul 22, 20207Jul 30, 202028Sep 9, 202035
-6.07%Jan 4, 20215Jan 8, 202121Feb 9, 202126
-5.59%Dec 8, 202013Dec 24, 20204Dec 31, 202017
-4.35%Jul 17, 20201Jul 17, 20202Jul 21, 20203
-4.26%Jul 15, 20201Jul 15, 20201Jul 16, 20202
-3.58%Nov 6, 20201Nov 6, 20201Nov 9, 20202
-2.22%Jul 9, 20201Jul 9, 20202Jul 13, 20203

Volatility Chart

Current Amryt Pharma plc volatility is 3.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%NovemberDecember2023FebruaryMarch
3.93%
22.09%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)